UBE3A promotes foam cell formation and counters remyelination by targeting ABCA1 for proteasomal degradation
8.0
来源:
Nature
发布时间:
2025-08-29 23:32
摘要:
UBE3A is identified as a crucial regulator of ABCA1 degradation in macrophages, impacting lipid metabolism and inflammatory responses. The study demonstrates that UBE3A deficiency enhances remyelination in models of demyelination, suggesting its potential as a therapeutic target in neurological disorders characterized by foamy macrophages.
原文:
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制,综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高,表示该新闻的价值越大,越值得关注。
价值维度分析
domain_focus
1.0分+1.0分
business_impact
0.5分+0.5分
scientific_rigor
1.5分+1.5分
timeliness_innovation
1.5分+1.5分
investment_perspective
2.5分+2.5分
market_value_relevance
1.0分+1.0分
team_institution_background
0.5分+0.5分
technical_barrier_competition
1.0分+1.0分
关键证据
UBE3A deficiency enhances remyelination in ex vivo and in vivo models.
UBE3A promotes ABCA1 ubiquitination and degradation in macrophages.
Loss of UBE3A reduces lipid accumulation and inflammatory responses.
真实性检查
否
AI评分总结
UBE3A is identified as a crucial regulator of ABCA1 degradation in macrophages, impacting lipid metabolism and inflammatory responses. The study demonstrates that UBE3A deficiency enhances remyelination in models of demyelination, suggesting its potential as a therapeutic target in neurological disorders characterized by foamy macrophages.